Cutaneous melanoma in the elderly: epidemiology and management

Authors: Lam, Bao; Ott, Patrick A; Pavlick, Anna C

Source: Aging Health, 1 June 2010, vol. 6, no. 3, pp. 383-392(10)


Buy & download fulltext article:

The full text article is temporarily unavailable.

We apologise for the inconvenience. Please try again later.


The incidence of melanoma is on the rise and the elderly population disproportionately accounts for the majority of melanoma cases and melanoma-related deaths. Advanced age is an independent adverse prognostic factor. Surgical resection remains the mainstay of treatment; however, elderly patients receive care that is nonconformant with well-established guidelines. Medical therapy options for high-risk and metastatic melanomas remain limited. New treatment approaches targeting the MAPK pathway, c-kit gene aberrations and novel immune-based therapies will pave the road to individualized and more effective treatment for invasive melanoma.

Keywords: BRAF; c-kit; elderly; melanoma; temozolomide; vaccine

Document Type: Research Article


Affiliations: 1Bellevue Hospital Center, New York, NY, USA

Publication date: June 1, 2010

Related content


Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page